Acute Respiratory Failure Clinical Trial
Official title:
Effect of Enteral Feeding's Macronutrient Composition on Inflammatory Mediators, Oxidative Stress and Outcomes in Intensive Care Unit Patients With Acute Respiratory Failure
Verified date | November 2015 |
Source | Shahid Beheshti University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Iran: Ministry of Health |
Study type | Interventional |
This study aimed to investigate the effect of enteral feeding's macronutrient composition on inflammatory mediators, oxidative stress and outcomes in Intensive Care Unit (ICU) patients with acute respiratory failure. In this double-blind randomized control trial, 42 patients of both sexes and diagnosed with acute respiratory failure in ICU that receive enteral feeding, will be randomly assigned to three groups of 14 each. First Intervention group; high-protein low-carbohydrate diet with high olive oil, the second intervention group; high-protein low-carbohydrate diet with high sunflower oil and control; high-protein kitchen formula. Intravenous levels of uric acid, high sensitive C-Reactive Protein (hs-CRP), Interleukin 6 (IL-6) and Total Antioxidant Capacity (TAC) measured at days 0 and 10. As well as, organ failure, duration of ventilation, length of ICU stay and mortality rates will be evaluated.
Status | Completed |
Enrollment | 48 |
Est. completion date | December 2015 |
Est. primary completion date | November 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - enrolled in ICU - age older than 18 years old - need to be mechanically ventilation - have enteral feeding - no previous diabetes - no previous HIV infection - no previous nervous system - no previous liver failure - no previous nephrotic syndrome - not passed more than 48 hours from diagnose of acute respiratory failure Exclusion Criteria: - death at less than three days of enteral feeding administration - extubation at less than three days of enteral feeding administration |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
Iran, Islamic Republic of | Faculty of Nutrition Sciences and Food Technology | Tehran |
Lead Sponsor | Collaborator |
---|---|
Zahra Vahdat Shariatpanahi |
Iran, Islamic Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | length of ventilation | The number of days from the patient intubation to his/her extubation | The number of days at least 3, to which days that patient extubated | No |
Secondary | Levels of high sensitive C-Reactive Protein (hs-CRP) in patient's vein blood | 10 days | No | |
Secondary | Levels of Total Antioxidant Capacity (TAC) in patient's vein blood | 10 days | No | |
Secondary | Levels of uric acid in patient's vein blood | 10 days | No | |
Secondary | Levels of Interleukin 6 (IL-6) in patient's vein blood | 10 days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05144633 -
Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)
|
||
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Recruiting |
NCT03021902 -
Nutrition and Exercise in Critical Illness
|
Phase 2 | |
Completed |
NCT02902146 -
Bougie Use in Emergency Airway Management
|
N/A | |
Completed |
NCT02901158 -
Esophageal Manometry in Mechanically Ventilated Patients
|
||
Completed |
NCT02236559 -
High Flow Therapy for the Treatment of Respiratory Failure in the ED
|
N/A | |
Recruiting |
NCT02056093 -
Comparison of Proportional Assist Ventilation And Neurally Adjusted Ventilator Assist
|
N/A | |
Terminated |
NCT01083277 -
Variable Ventilation During Acute Respiratory Failure
|
N/A | |
Not yet recruiting |
NCT01668368 -
Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance
|
N/A | |
Completed |
NCT01462279 -
Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness
|
N/A | |
Completed |
NCT01114022 -
Prevention Inhalation of Bacterial by Using Endotracheal Tube Balloon Polyvinyl Chloride or Polyurethane
|
N/A | |
Active, not recruiting |
NCT01058421 -
Treatment of Critical Illness Polyneuromyopathy
|
Phase 2 | |
Completed |
NCT00252616 -
Timing of Target Enteral Feeding in the Mechanically Ventilated Patient
|
Phase 2/Phase 3 | |
Recruiting |
NCT04098094 -
Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
|
||
Recruiting |
NCT06051292 -
Decremental Esophageal Catheter Filling Volume Titration For Transpulmonary Pressure Measurement
|
N/A | |
Completed |
NCT04601090 -
Survival Rates and Longterm Outcomes After COVID-19
|
||
Recruiting |
NCT05423301 -
Global Physiotherapy in ICU Patients With High Risk Extubation Failure
|
N/A | |
Completed |
NCT02447692 -
Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study
|
N/A | |
Completed |
NCT04016480 -
HFNC During Bronchoscopy for Bronchoalveolar Lavage
|
N/A | |
Completed |
NCT04507425 -
High Flow Nasal Cannula With Noninvasive Ventilation
|
N/A |